StockData

Universe Pharmaceuticals INC (UPC) stock

UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 29, 2026Score 5/30
$1.52−0.04 (-2.48%)

Close on Nov 18, 2026Market cap $857.01KP/E –Yield –

Universe Pharmaceuticals free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -$5.32B. The highest annual figure on record is $1.07B in fiscal 2023.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$5.32B–
FY2024Sep 30, 2024-$9.72B-1005.7%
FY2023Sep 30, 2023$1.07B–
FY2022Sep 30, 2022-$1.40M–
FY2021Sep 30, 2021-$2.50M-141.2%
FY2020Sep 30, 2020$6.06M-53.8%
FY2019Sep 30, 2019$13.12M–

More Universe Pharmaceuticals figures

See a number that looks wrong?